Although PRS have been shown to have a smaller contribution to risk modification in carriers of PV in BRCA1 and BRCA2 than in non-carriers, recent data indicates that modification of risk in other moderate-penetrance BC genes is similar to that observed in women without a PV9,62,63. The gene discussed is BRCA2; the disease is breast cancer.